PolarCool extends PolarCap® agreement with Ystad IF

The med-tech company PolarCool AB (publ.) has extended its agreement with the Swedish handball team Ystad IF. The Swedish multiple champion team has included treatment with PolarCap® in their concussion management routines since 2021.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussions. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

Handball is one of PolarCool's priority markets and the company, currently has existing agreements in both Switzerland and Germany. Ystad IF, have extended their current agreement and became the first handball club in Sweden to provide treatment with the PolarCap® System by signing an initial agreement in 2021.

PolarCool CEO Erik Andersson comments;

-We are happy that Ystad IF have extended the agreement, as they wish to continue to prioritize player safety. Ystad IF's medical team, led by Dr Daniel Jerrhag, is a pioneer in Swedish handball, and it is gratifying that PolarCap has become an important part of their concussion routines.

The extension with Ystad IF is strategically important, even if the financial significance of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.